Insider Transactions in Q2 2018 at Crispr Therapeutics Ag (CRSP)
Insider Transaction List (Q2 2018)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 05
2018
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
920
-4.78%
|
$11,040
$12.51 P/Share
|
|
Jun 05
2018
|
Kurt Von Emster Director |
SELL
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
2,000
-9.42%
|
$10,000
$5.75 P/Share
|
|
Jun 04
2018
|
Samarth Kulkarni Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
741
-0.5%
|
$49,647
$67.13 P/Share
|
|
Jun 01
2018
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
15,000
-4.68%
|
$1,020,000
$68.78 P/Share
|
|
Jun 01
2018
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+8.4%
|
$15,000
$1.81 P/Share
|
|
May 17
2018
|
Rodger Novak President |
SELL
Open market or private sale
|
Direct |
75,000
-6.13%
|
$4,500,000
$60.0 P/Share
|
|
May 17
2018
|
Rodger Novak President |
BUY
Exercise of conversion of derivative security
|
Direct |
75,000
+3.02%
|
$525,000
$7.91 P/Share
|
|
May 15
2018
|
Thomas Woiwode Director |
SELL
Open market or private sale
|
Indirect |
44,000
-3.22%
|
$2,552,000
$58.35 P/Share
|
|
May 15
2018
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
44,000
-3.22%
|
$2,552,000
$58.35 P/Share
|
|
May 14
2018
|
Ali Behbahani |
BUY
Other acquisition or disposition
|
Direct |
199
+50.0%
|
-
|
|
May 14
2018
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
400,000
-4.52%
|
$21,600,000
$54.43 P/Share
|
|
May 11
2018
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
250,000
-4.58%
|
$13,000,000
$52.52 P/Share
|
|
May 08
2018
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Direct |
9,241
-11.06%
|
$462,050
$50.77 P/Share
|
|
May 08
2018
|
Thomas Woiwode Director |
SELL
Open market or private sale
|
Direct |
1,653
-22.7%
|
$84,303
$51.45 P/Share
|
|
May 07
2018
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
119,709
-4.08%
|
$5,985,450
$50.79 P/Share
|
|
May 07
2018
|
Thomas Woiwode Director |
SELL
Open market or private sale
|
Indirect |
119,709
-4.08%
|
$5,985,450
$50.79 P/Share
|
|
Apr 30
2018
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
30,566
-2.03%
|
$1,528,300
$50.28 P/Share
|
|
Apr 30
2018
|
Thomas Woiwode Director |
SELL
Open market or private sale
|
Indirect |
30,566
-2.03%
|
$1,528,300
$50.28 P/Share
|
|
Apr 27
2018
|
Thomas Woiwode Director |
SELL
Open market or private sale
|
Indirect |
11,648
-0.77%
|
$582,400
$50.04 P/Share
|
|
Apr 27
2018
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
11,648
-0.77%
|
$582,400
$50.04 P/Share
|
|
Apr 26
2018
|
Thomas Woiwode Director |
SELL
Open market or private sale
|
Indirect |
210,610
-12.18%
|
$10,530,500
$50.12 P/Share
|
|
Apr 26
2018
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
210,610
-12.18%
|
$10,530,500
$50.12 P/Share
|
|
Apr 24
2018
|
Versant Venture Capital V, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
22,841
-1.3%
|
$1,142,050
$50.9 P/Share
|
|
Apr 24
2018
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
22,841
-1.3%
|
$1,142,050
$50.9 P/Share
|
|
Apr 24
2018
|
Thomas Woiwode Director |
SELL
Open market or private sale
|
Indirect |
22,841
-1.3%
|
$1,142,050
$50.9 P/Share
|
|
Apr 23
2018
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
101,994
-5.5%
|
$5,099,700
$50.83 P/Share
|
|
Apr 23
2018
|
Thomas Woiwode Director |
SELL
Open market or private sale
|
Indirect |
101,994
-5.5%
|
$5,099,700
$50.83 P/Share
|
|
Apr 23
2018
|
Versant Venture Capital Iv, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
101,994
-5.5%
|
$5,099,700
$50.83 P/Share
|
|
Apr 20
2018
|
Bradley J Ph D Bolzon Director |
BUY
Other acquisition or disposition
|
Direct |
16,262
+26.99%
|
-
|
|
Apr 20
2018
|
Bradley J Ph D Bolzon Director |
SELL
Other acquisition or disposition
|
Indirect |
592,918
-45.44%
|
-
|
|
Apr 20
2018
|
Bradley J Ph D Bolzon Director |
BUY
Other acquisition or disposition
|
Indirect |
92,918
+50.0%
|
-
|
|
Apr 20
2018
|
Thomas Woiwode Director |
BUY
Other acquisition or disposition
|
Direct |
2,323
+24.19%
|
-
|
|
Apr 20
2018
|
Thomas Woiwode Director |
SELL
Other acquisition or disposition
|
Indirect |
592,918
-45.44%
|
-
|
|
Apr 20
2018
|
Thomas Woiwode Director |
BUY
Other acquisition or disposition
|
Indirect |
92,918
+50.0%
|
-
|
|
Apr 20
2018
|
Versant Venture Capital Iv, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
592,918
-45.44%
|
-
|
|
Apr 20
2018
|
Versant Venture Capital Iv, L.P. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
92,918
+50.0%
|
-
|